Hall; Ralph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hall; Ralph.The latest application filed is for "system and method for stimulating the heart in combination with cardiac rhythm management pharmaceuticals".

Company Profile

0.14.10

Hall; Ralph - North Oaks MN
Hall; Ralph - North Oak MN
Hall; Ralph - King of Prussia PA
Hall; Ralph - Villanova PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
System and method for stimulating the heart in combination with cardiac rhythm management pharmaceuticals Grant 10,549,102 - Mower , et al. Fe	2020-02-04
System and method for stimulating the heart in combination with cardiac rhythm management pharmaceuticals Grant 9,943,692 - Mower , et al. April 17, 2	2018-04-17
System and method for stimulating the heart via the vagus nerve Grant 9,616,236 - Mower , et al. April 11, 2	2017-04-11
System and method for stimulating the heart using sub-threshold biphasic stimulation Grant 9,610,446 - Mower , et al. April 4, 2	2017-04-04
System And Method For Stimulating The Heart In Combination With Cardiac Rhythm Management Pharmaceuticals App 20170080224 - MOWER; Morton M. ; et al.	2017-03-23
System and method for stimulating the heart via storage of multi-waveforms in a cardiac stimulation device Grant 9,566,446 - Mower , et al. February 14, 2	2017-02-14
System and method for stimulating the heart in combination with cardiac rhythm management pharmaceuticals Grant 9,566,445 - Mower , et al. February 14, 2	2017-02-14
System and method for stimulating the heart using sub-threshold biphasic stimulation Grant 9,446,247 - Mower , et al. September 20, 2	2016-09-20
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy Grant 8,058,282 - Adams , et al. November 15, 2	2011-11-15
2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one Compounds And Compositions For Use In Therapy App 20110046109 - Adams; Jerry L. ; et al.	2011-02-24
Novel Compounds App 20110009625 - Adams; Jerry L. ; et al.	2011-01-13
2,4,5-Trisubstituted pyrimidine compounds Grant 7,759,486 - Adams , et al. July 20, 2	2010-07-20
Novel Compounds App 20090105478 - ADAMS; JERRY L. ; et al.	2009-04-23
Novel Compounds App 20080033170 - Adams; Jerry L. ; et al.	2008-02-07
Novel Compounds App 20080032969 - Adams; Jerry L. ; et al.	2008-02-07
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds Grant 7,323,472 - Adams , et al. January 29, 2	2008-01-29
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds Grant 7,314,881 - Adams , et al. January 1, 2	2008-01-01
4-amino substituted-6-aryl/heteroaryl substituted-2-methylsulfanyl-pyrimidine-5-carbaldehyde intermediates Grant 7,314,934 - Adams , et al. January 1, 2	2008-01-01
3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors Grant 7,053,099 - Adams , et al. May 30, 2	2006-05-30
Novel Compounds App 20050203109 - Adams, Jerry L. ; et al.	2005-09-15
3,4-Dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors App 20050075352 - Adams, Jerry L. ; et al.	2005-04-07
Novel compounds App 20040209901 - Adams, Jerry L. ; et al.	2004-10-21
3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors Grant 6,759,410 - Adams , et al. July 6, 2	2004-07-06
Novel compounds App 20040116697 - Adams, Jerry L. ; et al.	2004-06-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.